Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition

Thromb Res. 2011 Oct;128(4):e24-8. doi: 10.1016/j.thromres.2011.05.004. Epub 2011 May 31.

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is associated with an increased risk for thromboembolic events. We investigated thrombin generation profiles in COPD patients and their dependence on plasma factor/inhibitor composition.

Methods: Factors (f) (fII, fV, fVII, fVIII, fIX, fX), antithrombin, protein C (PC) and free tissue factor pathway inhibitor (fTFPI) from 60 COPD patients (aged 64.2 ± 10.1 years; a mean forced expiratory volume in 1 second [FEV(1)], 55.6 ± 15.8% of predicted values) were compared with those for 43 controls matched for age, sex, weight and smoking. Patients receiving anticoagulation were excluded. Using each individual's plasma coagulation protein composition, tissue factor-initiated thrombin generation was assessed computationally.

Results: COPD patients had higher fII (115 ± 16 vs 102 ± 10%, p < 0.0001), fV (114 ± 19 vs 102 ± 12%, p = 0.0002), fVII (111 ± 15 vs 102 ± 17%, p = 0.002), fVIII (170 ± 34 vs 115 ± 27%, p < 0.0001), and fIX (119 ± 21 vs 107 ± 17%, p = 0.003), and lower fTFPI (17.7 ± 3.2 vs 18.9 ± 3.2 ng/ml, p = 0.047) compared with controls, while fX, antithrombin, and PC were similar in both groups. Computational thrombin generation profiles showed that compared with controls, COPD patients had higher maximum thrombin levels (+28.3%, p < 0.0001), rates of thrombin generation (+46.1%, p < 0.0001) and total thrombin formation (+14.4%, p < 0.001), together with shorter initiation phase of thrombin generation (p < 0.0001) and the time to maximum thrombin levels (p < 0.0001). Thrombin generation profiles in COPD patients can be normalized via correction of fII, fVIII , fIX and TFPI. The severity of COPD and inflammatory markers were not associated with thrombin generation profiles.

Conclusions: Prothrombotic phenotype in COPD patients is largely driven by increased prothrombin, fVIII, fIX, and lower fTFPI.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Antithrombins / blood
  • Blood Coagulation Factor Inhibitors / blood*
  • Blood Coagulation Factors / metabolism*
  • Blood Coagulation Tests
  • Blood Coagulation*
  • Case-Control Studies
  • Female
  • Forced Expiratory Volume
  • Humans
  • Kinetics
  • Lipoproteins / blood
  • Lung / physiopathology
  • Male
  • Middle Aged
  • Phenotype
  • Poland
  • Protein C / metabolism
  • Pulmonary Disease, Chronic Obstructive / blood*
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Thrombin / metabolism*
  • Vital Capacity

Substances

  • Antithrombins
  • Blood Coagulation Factor Inhibitors
  • Blood Coagulation Factors
  • Lipoproteins
  • Protein C
  • lipoprotein-associated coagulation inhibitor
  • Thrombin